Parallel Advisors, LLC - QIAGEN NV ownership

QIAGEN NV's ticker is QGEN and the CUSIP is N72482123. A total of 278 filers reported holding QIAGEN NV in Q3 2023. The put-call ratio across all filers is 0.42 and the average weighting 0.2%.

Quarter-by-quarter ownership
Parallel Advisors, LLC ownership history of QIAGEN NV
ValueSharesWeighting
Q3 2023$20,817
+17.9%
514
+31.1%
0.00%0.0%
Q2 2023$17,652
+6.2%
392
+8.3%
0.00%0.0%
Q1 2023$16,627
+10.0%
362
+19.5%
0.00%0.0%
Q4 2022$15,111
+7.9%
303
-8.7%
0.00%0.0%
Q3 2022$14,000
-12.5%
332
-1.2%
0.00%0.0%
Q2 2022$16,000
-33.3%
336
-30.0%
0.00%0.0%
Q1 2022$24,000
-20.0%
480
-10.1%
0.00%0.0%
Q4 2021$30,000
+25.0%
534
+17.1%
0.00%0.0%
Q3 2021$24,000
+9.1%
456
+1.1%
0.00%0.0%
Q2 2021$22,000
-26.7%
451
-27.6%
0.00%0.0%
Q1 2021$30,000
-6.2%
623
+1.6%
0.00%
-50.0%
Q4 2020$32,000
+18.5%
613
+19.5%
0.00%0.0%
Q3 2020$27,000
+28.6%
513
+3.4%
0.00%
+100.0%
Q2 2020$21,000
-87.4%
496
-87.7%
0.00%
-92.9%
Q1 2020$167,000
+24.6%
4,030
+1.7%
0.01%
+40.0%
Q4 2019$134,0000.0%3,962
-2.2%
0.01%
-9.1%
Q3 2019$134,000
-17.3%
4,051
+1.6%
0.01%
-31.2%
Q2 2019$162,000
+23.7%
3,987
+24.2%
0.02%
+6.7%
Q1 2019$131,000
+19.1%
3,2100.0%0.02%0.0%
Q4 2018$110,000
-9.8%
3,2100.0%0.02%0.0%
Q3 2018$122,000
+617.6%
3,210
+548.5%
0.02%
+650.0%
Q2 2018$17,000
-37.0%
495
-40.9%
0.00%
-50.0%
Q1 2018$27,000
+3.8%
8380.0%0.00%0.0%
Q4 2017$26,000
-13.3%
838
-12.6%
0.00%
-20.0%
Q3 2017$30,0000.0%959
+5.8%
0.01%
-16.7%
Q2 2017$30,000
+7.1%
906
-1.9%
0.01%
+100.0%
Q1 2017$28,0009240.00%
Other shareholders
QIAGEN NV shareholders Q3 2023
NameSharesValueWeighting ↓
Nekton Capital Ltd. 1,114,127$52,587,00016.94%
SYCOMORE ASSET MANAGEMENT 836,103$38,866,0009.11%
Endurant Capital Management LP 398,221$18,796,0006.59%
SECTOR GAMMA AS 201,729$9,522,0002.13%
Grandeur Peak Global Advisors, LLC 625,173$29,508,0001.83%
DAVIDSON KEMPNER CAPITAL MANAGEMENT LP 2,173,011$101,905,0001.76%
ABEILLE ASSET MANAGEMENT SA 998,926$46,731,0001.65%
Pendal Group Ltd 3,208,379$151,436,0001.49%
Bank of Italy 637,371$29,593,0001.25%
Diametric Capital, LP 25,005$1,180,0000.87%
View complete list of QIAGEN NV shareholders